04.04.2013 Views

FORENSIC TOXICOLOGY - Bio Medical Forensics

FORENSIC TOXICOLOGY - Bio Medical Forensics

FORENSIC TOXICOLOGY - Bio Medical Forensics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

K18 The Effects of pH on the Oxidation of<br />

Ephedrine and Phenylpropanolamine<br />

Using Sodium Periodate<br />

Neil A. Fortner, MS*, Roger Rutter, BS, and Joseph Lane, BS,<br />

PharmChem, Inc., 4600 North Beach, Haltom City, TX 76137;<br />

Robert F. Turk, PhD, Center for Toxicology Services, Inc., 8231<br />

Lakeshore Villa Drive, Humble, TX 77346<br />

The attendees will better understand the impact that pH may have<br />

on the oxidation of ephedrine and phenylpropanolamine using sodium<br />

periodate.<br />

The use of sodium periodate to chemically oxidize common over<br />

the counter amphetamine like substances such as ephedrine, and phenylpropanolamine<br />

has become an accepted practice in forensic urine drug<br />

testing environments. However, very little information is available as to<br />

the effect that pH has on the efficiency of this oxidative procedure. The<br />

purpose of this study was to evaluate the potential of the production of<br />

amphetamine and methamphetamine in the presence of high concentrations<br />

(3,000,000 ng/ml) of ephedrine and phenylpropanolamine. A saturated<br />

sodium periodate solution and sodium hydroxide solution are<br />

added to the urine sample containing the drug and deuterated internal<br />

standards. The pH of this oxidation step is between 11 and 13. In this<br />

study, the sodium periodate was also adjusted to pH 4.4, 5.2, 9.1 and 9.3.<br />

Samples were extracted using solid phase technology, and derivatized<br />

with MBTFA to form the TFA derivative. GC/MS analysis was conducted<br />

using electron impact ionization using three ions for the native<br />

compound and two ions for the deuterated internal standard. A single<br />

point calibrator at 500 ng/ml was used to establish both qualitative and<br />

quantitative results. No amphetamine or methamphetamine was detected<br />

at any of the pH levels evaluated. This data suggests that the oxidation<br />

of ephedrine and phenylpropanolamine at levels as high as 3,000,000<br />

ng/ml by sodium periodate is effective when the pH is between 4.4<br />

and 13.<br />

pH, Ephedrine, Phenylpropanolamine<br />

K19 The Validity of Surrogate<br />

Reporting of Substance Use<br />

Hsiang-Ching Kung, PhD* and Jack Li, PhD, National Center for<br />

Health Statistics, CDC, 3311 Toledo Road, Room 7318, Hyattsville,<br />

MD 20782; Rong-Jen Hwang, PhD, Toxicology Laboratory Criminal<br />

Investigations Division, Santa Barbara County Sheriff-Coroner, 66<br />

South San Antonio Road, Santa Barbara, CA 93110<br />

After attending this presentation, attendees will have an understanding<br />

of evaluating the validity of surrogate reporting of substance<br />

use for the deceased.This study contribute to the understanding of<br />

factors involved in achieving high sensitivity and specificity of certain<br />

substances when contesting the validity of next-of-kin reporting versus<br />

toxicology reports.<br />

Introduction: Collection of substance use information for those<br />

who died unexpectedly often rely on proxy respondents or toxicology<br />

reports. Past research have examined surrogate reporting about the<br />

deceased characteristics. However, the direct assessment of proxy<br />

reporting of substance use versus toxicology report were rarely investigated.<br />

The purpose of this study were: 1) to use toxicology report as a<br />

gold standard to evaluate the validity of proxy reporting of substance<br />

use, and 2) to identify which drug groups that are more likely to be accurately<br />

reported by the surrogate.<br />

* Presenting Author<br />

Methods: The data for this study were obtained from the 1993<br />

National Mortality Followback Survey (NMFS) conducted by the<br />

National Center for Health Statistics, Centers for Disease Control and<br />

Prevention. With the permission from next-of-kin of the deceased, questionnaire<br />

data were linked to 3483 toxicology report collected from 1265<br />

medical examiner/coroner offices. Ten items that asking the deceased<br />

substance use behavior were selected from questionnaire and compared<br />

with toxicology report. In the interview questionnaire, substances were<br />

grouped into nine drug categories : alcohol, pain killer, sedative, tranquilizer,<br />

antidepressant, stimulant, cocaine, marijuana, and methadone.<br />

Sensitivity and specificity test were used to evaluate the validity of nextof-kin<br />

reporting. We defined sensitivity is the toxicology report GC/MS<br />

confirm positive of a substance used and next-of-kin also reported yes to<br />

that substance for the deceased. Specificity is the toxicology report<br />

GC/MS confirm negative of a substance used and next-of-kin also<br />

reported no to that substance for the deceased.<br />

Results and Discussion: The study results in the table below<br />

demonstrated that methadone and painkillers such as morphine, codeine<br />

and propoxyphene had 100% sensitivity. High sensitivity reflects that<br />

immunoassay procedures and confirmation techniques for these two categories<br />

of substance that were well developed and routinely executed for<br />

their identification in the laboratory. However, the sensitivity for other<br />

categories of substance use was low. The possible explanation for low<br />

sensitivity could be: 1) inability of the laboratory to detect substances<br />

that were not routinely screened and confirmed; 2) each substance has<br />

an unique halflife.<br />

Consumption of substances such as methamphetamine, cocaine, or<br />

alcohol few days prior to death often provides a negative lab result; 3)<br />

small quantity of substance use frequently causes a lab result below the<br />

detection limit; 4) detection time also varies depending upon analytical<br />

method used, drug metabolism, individual’s physical condition, fluid<br />

intake, and method and frequency of substance ingestion prior to death.<br />

Furthermore, cutoff values for positive substance vary from one laboratory<br />

to another. Regarding specificity, the survey revealed an average<br />

76% specificity indicating that proxy reporting of substance use has<br />

some degree of scientific certainty in general. However none of the individual<br />

categories of substance reached 100% specificity, meaning proxy<br />

respondents did not know whether the decedents had used substance<br />

prior to their death. Alcohol, on the other hand, has the lowest specificity.<br />

It is probably associated with proxy’s social, financial, psychological<br />

and legal implications. In conclusion, our study showed that both<br />

the toxicology report and proxy reporting provided important information<br />

in identifying forensic relevance for those who died unexpectedly.<br />

Nevertheless, shortfalls of each reporting system should be<br />

cautiously taken into consideration in result interpretation.<br />

Sensitivity Specificity<br />

Alcohol 0.93 0.26<br />

Pain Killer 1.00 0.73<br />

Sedative 0.36 0.88<br />

Tranquilizer 0.47 0.85<br />

Antidepressant 0.60 0.75<br />

Stimulant 0.41 0.93<br />

Cocaine 0.59 0.85<br />

Marijuana 0.58 0.80<br />

Methadone 1.00 0.90<br />

Validity, Toxicology Report, Surrogate Reporting<br />

212

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!